The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired common shares of ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD) between February 26, 2015 and March 11, 2015.

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of California. If you purchased or otherwise acquired ACADIA Pharmaceuticals Inc. ("ACADIA") securities between February 26, 2015 and March 11, 2015, your rights may be affected by this action. To get more information at no cost or obligation to you, go to:

HTTP://ZLK.9NL.COM/ACAD-INFOSHEET

The complaint alleges that the Company made false and misleading statements and/or failed to disclose material information regarding the timing of its submission of its New Drug Application to the FDA for Nuplazid.

On March 11, 2015, the Company announced it would delay submitting a New Drug Application for its drug Nuplazid. The Company also noted that Chief Executive Officer Uli Hacksell is retiring. Shares of ACADIA were down more than 20% on intraday trading the following day.

If you suffered a loss in Acadia you have until May 12, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/acadia-pharmaceuticals-acad.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free: (877) 363-5972
         Fax: (212) 363-7171
         www.zlk.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Acadia Pharmaceuticals Charts.
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Acadia Pharmaceuticals Charts.